Breakfast Series Features Dr. Janet Woodcock, Director of the FDA’s Center for Drug Evaluation and Research
Further information:
Related posts:
- Personalized medicine in warfarin therapy
- Warfarin Therapy And Personalized Medicine
- Pharmacodiagnostics and Personalized Medicine 2009 Markets, Challenges, Forecasts and Key Players Market Research Reports
- Cedars-Sinai Regenerative Medicine Institute to receive ALS Research Award
- Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept

Posted in